Abstract
Chemokines are a family of 8–10 kDa proteins with a wide range of biological activities including the regulation of leukocyte trafficking, modulation of haemopoietic cell proliferation and adhesion to extracellular matrix molecules. Using a panel of chemokine receptor-specific monoclonal antibodies (MoAb) in a multicolour flow cytometry approach we analysed the expression of the lymphocyte-associated chemokine receptors CXCR4, CXCR5, CCR5 and CCR6 in B cell acute lymphoblastic leukaemia (precursor B-ALL; six cases), B cell chronic lymphocytic leukaemia (B-CLL; 31 cases), multiple myeloma (10 cases), mantle cell lymphoma (MCL, four cases), follicular lymphoma (FL, three cases) and hairy cell leukaemia (HCL, five cases). We demonstrate that CXCR4, CXCR5 and CCR6 are differentially expressed in these B lymphoproliferative disorders depending on the maturational stage of the malignant B cell population investigated. In particular, we found that CXCR4 is strongly expressed on immature ALL blasts whereas no surface immunoreactivity for CXCR5, CCR5 and CCR6 was observed. By contrast, non-Hodgkin's lymphomas (NHLs) corresponding to more mature peripheral B cell subsets (ie B-CLL and MCL) exhibited high expression levels of CXCR4 and CXCR5. Analysis of terminally differentiated myeloma cells revealed a down-regulation of CXCR4, CXCR5 and CCR6. CCR5, which is not expressed in normal B cells, was also absent from the majority of NHLs. However, CCR5 staining was seen in three of five cases of HCL, representing the first example of cross-lineage aberrant chemokine receptor expression in malignant haemopoietic cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Murdoch C, Finn A . Chemokine receptors and their role in inflammation and infectious diseases Blood 2000 95: 3032–3043
Cyster JG . Chemokines and cell migration in secondary lymphoid organs Science 1999 286: 2098–2102
Bleul C, Wu L, Hoxie J, Springer T, Mackay C . The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes Proc Natl Acad Sci USA 1997 94: 1925–1930
Bowman EP, Campbell JJ, Soler D, Dong Z, Manlongat N, Picarella D, Hardy R, Butcher EC . Developmental switches in chemokine response profiles during B cell differentiation and maturation J Exp Med 2000 191: 1303–1318
Baggiolini M . Chemokines and leukocyte traffic Nature 1998 392: 565–568
Baba M, Imai T, Nishimura M, Kakizaki M, Takagi S, Hieshima K, Nomiyama H, Yoshie O . Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC J Biol Chem 1997 272: 14893–14898
Legler DF, Loetscher M, Roos RS, Clark-Lewis I, Baggiolini M, Moser B . B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5 J Exp Med 1998 187: 655–660
Drillenburg P, Pals ST . Cell adhesion receptors in lymphoma dissemination Blood 1900 95: 1900–1910
Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC . A revised European–American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group Blood 1994 84: 1361–1392
Höffkes H, Schmidtke G, Uppenkamp M, Schmucker U . Multiparametric immunophenotyping of B cells in peripheral blood of healthy adults by flow cytometry Clin Diagn Lab Immunol 1996 3: 30–36
Bene M, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer MB (EGIL) . Proposal for the immunological classification of acute leukemias Leukemia 1995 9: 1783
Aiuti A, Tavian M, Cipponi A, Ficara F, Zappone E, Hoxie J, Peault B, Bordignon C . Expression of CXCR4, the receptor for stromal cell-derived factor-1 on fetal and adult human lympho-hematopoietic progenitors Eur J Immunol 1999 29: 1823–1831
Förster R, Emrich T, Kremmer E, Lipp M . Expression of G-protein-coupled receptor BLR1 defines mature, recirculating B cells and a subset of T-helper memory cells Blood 1994 84: 830–840
Dürig J, Rosenthal C, Elmaagacli A, Heyworth C, Halfmeyer K, Kasper C, Novotny J, Dührsen U . Biological effects of stroma derived factor-1 on normal and CML CD34+ haemopoietic progenitor cells Leukemia 2000 14: 1652–1660
Damle R, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz J, Lichtman SM, Schulman P, Vinciguerra VP, Rai KR, Ferrarini M, Chiorazzi N . Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia Blood 1999 94: 1840–1847
Möhle R, Failenschmid C, Bautz F, Kanz L . Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1) Leukemia 1999 13: 1954–1959
Jones D, Benjamin RJ, Shahsafaei A, Dorfman DM . The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia Blood 2000 95: 627–632
Gunn M, Ngo V, Ansel K, Ekland E, Cyster J, Williams L . A B-cell-homimg chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1 Nature 1998 391: 799–803
Förster R, Mattis A, Kremmer E, Wolf E, Brem G, Lipp M . A putative chemokine receptor, BLR-1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen Cell 1996 87: 1037–1047
Kaiser E, Förster R, Wolf I, Ebensperger C, Kuehl W, Lipp M . The G-protein-coupled receptor BLR1 is involved in murine B-cell differentiation and is also expressed in neuronal tissues Eur J Immunol 1993 23: 2532–2539
Rollins BJ . Chemokines Blood 1997 90: 909–928
Dürig J, de Wynter EA, Kasper C, Cross MA, Chang J, Testa NG, Heyworth CM . Expression of macrophage inflammatory protein-1 receptors in human CD34(+) hematopoietic cells and their modulation by tumor necrosis factor-alpha and interferon-gamma Blood 1998 92: 3073–3081
Fedyk E, Ryyan D, Ritterman I, Springer T . Maturation decreases responsiveness of human bone marrow B lineage cells to stromal-derived factor 1 (SDF-1) J Leukoc Biol 1999 66: 667–673
Dürig J, Testa NG, Heyworth CM . Distinct biological effects of macrophage inflammatory protein-1alpha and stroma-derived factor-1alpha on CD34+ hemopoietic cells Stem Cells 1999 17: 62–71
Salgia R, Quackenbush E, Lin J, Souchkova N, Sattler M, Ewaniuk DS, Klucher KM, Daley GQ, Kraeft SK, Sackstein R, Alyea III EP, von Andrian UH, Chen LB, Gutierrez-Ramos J-C, Pendergast AM, Griffin JD . The bcr/abl oncogene alters the chemotactic response to stromal-derived factor-1alpha Blood 1999 94: 4233–4246
Acknowledgements
This work was supported by a grant from the Deutsche Forschungsgemeinschaft (SFB 545/B5).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dürig, J., Schmücker, U. & Dührsen, U. Differential expression of chemokine receptors in B cell malignancies. Leukemia 15, 752–756 (2001). https://doi.org/10.1038/sj.leu.2402107
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402107
Keywords
This article is cited by
-
Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances
Current Oncology Reports (2022)
-
Targeting chemokines for acute lymphoblastic leukemia therapy
Journal of Hematology & Oncology (2021)
-
CXCL13 plasma levels function as a biomarker for disease activity in patients with chronic lymphocytic leukemia
Leukemia (2021)
-
CXCR5 CAR-T cells simultaneously target B cell non-Hodgkin’s lymphoma and tumor-supportive follicular T helper cells
Nature Communications (2021)
-
Preliminary evidence of imaging of chemokine receptor-4-targeted PET/CT with [68Ga]pentixafor in non-Hodgkin lymphoma: comparison to [18F]FDG
EJNMMI Research (2020)